Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Dollar and Under Sleeper Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Due Diligence who wrote (6719)	5/12/1998 11:54:00 PM
From: Charger	Respond to of 8835

Jimbo - I spoke with the CEO of LaJolla Diagnostics (LAJD) today. Brief conversation as he was being photographed for some PR. Here are the bits that I got so far: 11 mill shares outstanding, 4 mill closely held (some restricted stock not exercisable til yr. 2001. This leaves approx. free trading of about 2.5 mill. These are the products they currently offer: Feverfew Nasal MistT Living Water Eye LotionT OptoPetT Eye Wash From their web site: La Jolla Diagnostics Inc. is a publicly held corporation with corporate headquarters in La Jolla, California, and laboratory facilities nearby. The Company's management and scientists have extensive expertise in a wide variety of health care areas including basic science, clinical investigation, product development and marketing and dealing with the FDA. Some of the Company's products are based on a unique patented technology, "ClusterWater"(U.S. Patent 5711950). La Jolla Diagnostics has two divisions, a Health Care Products Division which is developing and marketing ophthalmic solutions, nasal sprays, and licensing technologies for drug delivery, and a Diagnostic Division which is developing and marketing diagnostic products. In addition the Company has a working relationship with some of the premier scientific leaders of Russia and other countries of the ex-Soviet Union. Their recent news release: quote.yahoo.com These products will be prepared using water processed by a recently patented technology* to form ClusterWater(TM). While remaining chemically identical with unprocessed water, ClusterWater forms polywater complexes which enhance the effectiveness of biological solutions. *U.S. Patent 5711950 ClusterWater is also used in the formulation of the following products for which La Jolla Diagnostics is beginning to receive bulk orders: Feverfew Nasal Mist(TM), a patent pending moisturizing nasal spray, MigraSpray(TM) a saline solution containing the herb feverfew (commonly used as a treatment for migraine headaches) and designed to be sprayed under the tongue, Living Water Eye Lotion(TM), a saline solution which cleanses and soothes the eye without interfering with natural functions, and OptoPet(TM) Eye Wash for cleansing the eyes of dogs and cats and removing mucous which causes fur stains beneath the eyes, a major problem in certain breeds. The new products which they are currently working on patenting will incorporated their already patented product for use in nasal spray and allergy treatment but has a "new type of treatment delivery" about which Mr. Brucker could not be specific until patenting process is further along. They are selling their antisera inventory as they feel the more recent products are more popular. That is as far as I got. More later. Charger

To: Due Diligence who wrote (6719)	5/14/1998 7:07:00 PM
From: JOE TURMAINE	Read Replies (1) \| Respond to of 8835

Jimbo, did you follow Araldica Wineries (OTC BB:AWLT) at one time. They just announced that they are taking their product line to the internet. araldica.com Check it out!! JOE

To: Due Diligence who wrote (6719)	5/15/1998 8:33:00 AM
From: Charger	Respond to of 8835

Ikar to Meet with International Monetary Fund biz.yahoo.com Charger

To: Due Diligence who wrote (6719)	6/5/1998 10:01:00 AM
From: JOE TURMAINE	Respond to of 8835

Jimbo, Friday, Jun 5 1998 9:58AM ET Reply # of 3133 biz.yahoo.com Friday June 5, 6:02 am Eastern Time Company Press Release National Rehab Properties Inc. Announces Year End Results and Monthly Sales NEW ORLEANS--(BUSINESS WIRE)--June 5, 1998--National Rehab Properties Inc. (OTC BB:NRPI - news) Friday announced Audited results of the year ended Sept. 30, 1997. The entire Audit has been listed in NRPI's Internet Web Site: nrpi.com. The company expects to be a reporting company by the end of its fiscal year 1998. The company Friday reported that its monthly sales revenues were $379,500, the largest monthly sales volume for the company ever. The company expects the pace of closings to increase for the balance of the year. The company expects to complete 100 sales by Dec. 31, 1998. The company is in the process of rehabilitating homes in New Orleans and selling the renovated homes to ''first time homebuyers'' through ''affordable housing'' programs. The homes are being sold to first-time homebuyers. Large areas of New Orleans are primarily two family homes and NRPI is converting those two family homes into single family homes for working families. Commenting, Richard Astrom, president and chief executive officer, said: ''We started in August 1997 to buy homes in New Orleans and we have become a leader in sales and the rehabilitation of homes in the City of New Orleans. The company will remain profitable and is continuing to buy homes for resale based on the favorable conditions for profitability we find in this market. The company not only benefits shareholders by engaging in a profitable business venture, but also benefits the community by rehabilitating blighted neighborhoods.'' Certain of the above statements may be forward looking statements that involve risks and uncertainties. In such instances, actual results could differ materially as a result of a variety of factors, including competitive developments and risk factors listed from time to time in the company's SEC reports. Contact: National Rehab Properties Inc. Richard Astrom, President and CEO 504/525-2777 or Growth International Ltd. George Guttman, President 718/951-0260 or Investor Services Joe Gort, 800/716-5147 Good luck to all of us!!! JOE